Citation Impact
Citing Papers
Toxicities of chimeric antigen receptor T cells: recognition and management
2016
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
Origin of Antibiotics and Antibiotic Resistance, and Their Impacts on Drug Development: A Narrative Review
2023 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
TEER Measurement Techniques for In Vitro Barrier Model Systems
2015 Standout
Triple-negative breast cancer molecular subtyping and treatment progress
2020 Standout
What is polypharmacy? A systematic review of definitions
2017 Standout
An overview of clinical decision support systems: benefits, risks, and strategies for success
2020 Standout
Different responses to dexamethasone and prednisolone in the same depressed patients
2006
Neutrophil Extracellular Traps Go Viral
2016
Increased Thrombopoiesis and Platelet Activation in Hantavirus-Infected Patients
2015 StandoutNobel
The use of newer antiepileptic drugs in patients with renal failure
2011
Voriconazole Metabolism, Toxicity, and the Effect of Cytochrome P450 2C19 Genotype
2014
The re-emergence of natural products for drug discovery in the genomics era
2015 Standout
Efficacy and Safety of Valganciclovir vs. Oral Ganciclovir for Prevention of Cytomegalovirus Disease in Solid Organ Transplant Recipients
2004
High-priority and low-priority drug–drug interactions in different international electronic health record systems: A comparative study
2018
The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak – an update on the status
2020 Standout
Calcineurin Inhibitor Nephrotoxicity
2009 Standout
General Principles of Antimicrobial Therapy
2011
Polypharmacy and Renal Failure in Nursing Home Residents: Results of the Inappropriate Medication in Patients with Renal Insufficiency in Nursing Homes (IMREN) Study
2015
Drug dosing in continuous renal replacement therapy: general rules
2007
Has the era of individualised medicine arrived for antifungals? A review of antifungal pharmacogenomics
2011
A comparative randomised study of valacyclovir vs. oral ganciclovir for cytomegalovirus prophylaxis in renal transplant recipients
2005
An ELISA Based Binding and Competition Method to Rapidly Determine Ligand-receptor Interactions
2016 StandoutNobel
Renal cell apoptosis induced by nephrotoxic drugs: cellular and molecular mechanisms and potential approaches to modulation
2007
Hepatic inflammation and progressive liver fibrosis in chronic liver disease
2014
Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions
2014 Standout
Mesenchymal stem cells in health and disease
2008 Standout
Macrophages in immunoregulation and therapeutics
2023 Standout
Valganciclovir in Adult Solid Organ Transplant Recipients
2009
Cyclosporine markedly raises the plasma concentrations of repaglinide
2005
Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline
2016 Standout
Ganciclovir
2018
Challenges of antibacterial discovery revisited
2010
Dose-Response Analysis Using R
2015 Standout
General Adaptation in Critical Illness: Glucocorticoid Receptor-alpha Master Regulator of Homeostatic Corrections
2020
Understanding variability with voriconazole using a population pharmacokinetic approach: implications for optimal dosing
2014
Insulin-Like Growth Factor-1 Sustains Stem Cell–Mediated Renal Repair
2007
Microfluidic organs-on-chips
2014 Standout
Integration ofin silicoandin vitroplatforms for pharmacokinetic–pharmacodynamic modeling
2010
What is new in the management of rapidly progressive glomerulonephritis?
2015
European Resuscitation Council Guidelines for Resuscitation 2010 Section 4. Adult advanced life support
2010 Standout
Cyclodextrins as Functional Excipients: Methods to Enhance Complexation Efficiency
2012
Evidence of Disseminated Intravascular Coagulation in a Hemorrhagic Fever with Renal Syndrome—Scoring Models and Severe Illness
2011
Antithrombotic therapy in the elderly: expert position paper of the European Society of Cardiology Working Group on Thrombosis
2015
Management of Chronic Kidney Disease Patients in the Intensive Care Unit: Mixing Acute and Chronic Illness
2017 Standout
The HPA axis in major depression: classical theories and new developments
2008 Standout
The Third International Consensus Guidelines on the Management of Cytomegalovirus in Solid-organ Transplantation
2018 Standout
Principles of antibacterial dosing in continuous renal replacement therapy
2009
Vasopressin, Epinephrine, and Corticosteroids for In-Hospital Cardiac Arrest
2009
Administration of Voriconazole in Patients With Renal Dysfunction
2012
Infections in Patients with Multiple Myeloma in the Era of High‐Dose Therapy and Novel Agents
2009
The Hill equation: a review of its capabilities in pharmacological modelling
2008
Voriconazole pharmacokinetics and exposure–response relationships: Assessing the links between exposure, efficacy and toxicity
2014
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
2013 Standout
Improving antibiotic dosing in special situations in the ICU
2012
Steady-state pharmacokinetics and metabolism of voriconazole in patients
2013
Recent advances in understanding the antibacterial properties of flavonoids
2011 Standout
Cyclodextrins
2012
Chimeric antigen receptor T-cell therapy — assessment and management of toxicities
2017 Standout
A guide to cancer immunotherapy: from T cell basic science to clinical practice
2020 Standout
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
2014 Standout
Albumin-bound paclitaxel in solid tumors: clinical development and future directions
2015
Review of the Basic and Clinical Pharmacology of Sulfobutylether-β-Cydodextrin (SBECD)
2010
Using physiologically-based pharmacokinetic-guided “body-on-a-chip” systems to predict mammalian response to drug and chemical exposure
2014
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Toward a unified approach to dose–response modeling in ecotoxicology
2010
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Complexation of Polyoxometalates with Cyclodextrins
2015 StandoutNobel
Nanozymes: Classification, Catalytic Mechanisms, Activity Regulation, and Applications
2019 Standout
Safety and Tolerability of Voriconazole in Patients with Baseline Renal Insufficiency and Candidemia
2012
Antibiotic Use in Agriculture and Its Consequential Resistance in Environmental Sources: Potential Public Health Implications
2018 Standout
Synthetic Siglec-9 Agonists Inhibit Neutrophil Activation Associated with COVID-19
2021 StandoutNobel
Part 9: Post–Cardiac Arrest Care
2010 Standout
Echinococcosis: Advances in the 21st Century
2019 Standout
Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients
2009 Standout
Review: A History of Cyclodextrins
2014 Standout
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
Analysis of Past and Present Synthetic Methodologies on Medicinal Chemistry: Where Have All the New Reactions Gone?
2015 Standout
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
2015 Standout
Natural Products in Medicine: Transformational Outcome of Synthetic Chemistry
2014
Chimeric Antigen Receptor Therapy
2018 Standout
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
Nanofiltration membranes review: Recent advances and future prospects
2014 Standout
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Endothelial Activation and Repair During Hantavirus Infection: Association with Disease Outcome
2014
Inflammatory responses and inflammation-associated diseases in organs
2017 Standout
Pharmacogenomics of the Triazole Antifungal Agent Voriconazole
2011
Organic solvent nanofiltration: A platform for removal of genotoxins from active pharmaceutical ingredients
2011
Natural Products as Sources of New Drugs from 1981 to 2014
2016 Standout
Clinical Practice Guideline: Sudden Hearing Loss (Update)
2019 Standout
Hearing Changes After Intratympanically Applied Steroids for Primary Therapy of Sudden Hearing Loss: A Meta-analysis Using Mathematical Simulations of Drug Delivery Protocols
2016
Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors
2016 Standout
Multiple Myeloma
2011 Standout
Ultrasound Elastography: Review of Techniques and Clinical Applications
2017 Standout
Multicenter Study of Voriconazole Pharmacokinetics and Therapeutic Drug Monitoring
2012
Works of David Czock being referenced
Determination of the pharmacokinetics of cerivastatin when administered in combination with sirolimus and cyclosporin A in patients with kidney transplant, and review of the relevant literature
2003
Modulators of Very Low Voriconazole Concentrations in Routine Therapeutic Drug Monitoring
2010
New AUC-Based Method to Estimate Drug Fraction Removed by Hemodialysis
2004
Pharmacokinetics and pharmacodynamics of antimicrobial drugs
2009
Review on Pharmacokinetics and Pharmacodynamics and the Aging Kidney
2010
Mechanism-based pharmacokinetic–pharmacodynamic modeling of antimicrobial drug effects
2007
Activity of mefloquine and mefloquine derivatives against Echinococcus multilocularis
2018
Renal proximal tubular cell growth and differentiation are differentially modulated by renotropic growth factors and tyrosine kinase inhibitors
2001
Pharmacokinetics and Pharmacodynamics of Systemically Administered Glucocorticoids
2005
Pharmacokinetics and total elimination of meropenem and vancomycin in intensive care unit patients undergoing extended daily dialysis*
2005
Drug Therapy in Patients With Chronic Renal Failure
2010
What, if all alerts were specific – Estimating the potential impact on drug interaction alert burden
2014
Pharmacokinetics of Moxifloxacin and Levofloxacin in Intensive Care Unit Patients Who Have Acute Renal Failure and Undergo Extended Daily Dialysis
2006
Pharmacodynamic dose adjustment in renal failure: importance of the Hill coefficient
2006
PK-PD curve-fitting problems with the Hill equation? Try one of the 1-exp functions derived from Hodgkin, Douglas or Gompertz
2002
Rituximab in two cases of Goodpasture's syndrome
2009
Pharmacokinetics of Sulfobutylether-Beta-Cyclodextrin and Voriconazole in Patients with End-Stage Renal Failure during Treatment with Two Hemodialysis Systems and Hemodiafiltration
2010
Dose adjustment of ciprofloxacin in renal failure: reduce the dose or prolong the administration interval?
2005
Thrombocytopenia and Acute Renal Failure in Puumala Hantavirus Infections
2004
Pharmacokinetics of valganciclovir and ganciclovir in renal impairment
2002
Individualized drug dosage in patients treated with continuous hemofiltration
1999